Erratum: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF) (Journal of Assisted Reproduction and Genetics (2006) 23, 1, (1-13) DOI: 10.1007/s10815-005-9013-1);Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF)

Journal of Assisted Reproduction and Genetics

Volumn 23, Issue 1, 2006, Pages 1-13

  Clark, David A ^a   Coulam, Carolyn B ^b   Stricker, Raphael B ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Millenova Laboratories   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Evidence based medicine; Infertility; IVIG; Meta analysis

Indexed keywords

CHROMIUM 51; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

BIRTH RATE; CLINICAL TRIAL; DATA ANALYSIS; DRUG MECHANISM; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; IN VITRO STUDY; META ANALYSIS; NATURAL KILLER CELL; PREGNANCY DISORDER; PREGNANCY RATE; PRIORITY JOURNAL; RADIOASSAY; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33645362933     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-006-9057-x     Document Type: Erratum

References (77)

1. Sewell WAC, Jolles S: Immunomodulatory action of intravenous immunoglobulins. Immunology 2002;107:387-393
2. Daya S, Gunby J, Clark DA: Intravenous immunoglobulins therapy for recurrent spontaneous abortion: A meta-analysis. Am J Reprod Immunol 1998;39:69-76
3. Daya S, Gunby J, Porter F, Scott J, Clark DA: Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Hum Reprod Update 1999;5:475-482
4. Stephenson MS, Fluker MR: Treatment of repeated unexplained in vitro fertilization failures with intravenous immunoglobulins: A randomized, placebo-controlled Canadian trial. Fertil Steril 2000;74:1108-1113
5. McDonough PG: "In silico experiments" - yes, but the great western cowboy "random chance" is still alive. Fertil Steril 2001;76:639-640
6. Sher G, Fisch JD: "In silico experiments" - yes, but the great western cowboy "random chance" is still alive. Fertil Steril 2001;76:636-637
7. Stricker RB, Steinleitner A: "In silico experiments" - yes but the great western cowboy "random chance" is still alive. Fertil Steril 2001;76:637-639
8. Kleinstein J, Khanga O, Gips H, Kunzel W: Intravenous immunoglobulins increase pregnancy rate in an IVF program. In: Scientific Program and Abstracts of the Society for Gynecological Investigation, Chicago 1994;248 (Abstr #P108)
9. De Placido G, Zullo F, Mollo A, Cappiello F, Nazzaro A, Colacuri N, Palumbo G: Intravenous immunoglobulins (IVIG) in the prevention of implantation failures. Ann NY Acad Sci 1994;734:232-234
10. Sher G, Maassarani G, Zouves C, Feinman M, Sohn S, Matzner W, Chong P, Ching W: The use of combined heparin/aspirin and immunoglobulins G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 1998;39:223-225
11. Coulam CB, Roussev RG: Role of T cell activation and inhibition markers in diagnosing women experiencing immunological implantation failure after in vitro fertilization and embryo transfer. Am J Reprod Immunol 2002;48(Abstr # I12):138
12. Stricker RB, Steinleitner A, Winger EE: Intravenous immunoglobulins (IVIG) therapy for immunologic abortion. Clin Appl Immunol Rev 2002;2:187-199
13. Clark DA, Coulam CB, Daya S, Chaouat G: Unexplained sporadic and recurrent miscarriage in the new millennium: A critical analysis of immune mechanisms and treatment. Hum Reprod Update 2001;7:501-511
14. Clark DA, Chaouat G: Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am J Reprod Immunol 2005;53:13-20
15. American Society for Reproductive Medicine, Assisted Reproductive Technology Registry: Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2002;78:918-931
16. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet 2005;365:1687-1717
17. The Recurrent Miscarriage Immunotherapy Trialists Group: Worldwide collaborative observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994;32:55-72
18. Clark DA, Gunby J, Daya S: The use of allogeneic leukocytes of IV IgG for the treatment of patients with recurrent spontaneous abortion. Transfus Med Rev 1997;11:85-94
19. Concato J, Shah N, Horowitz RI: Randomized, controlled trials, observational studies, and hierarchy of research designs. N Engl J Med 2000;342:1887-1892
20. Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886
21. Ioannidis JPA, Haidich AB, Pappa M, Pantazia N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J: Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-830
22. Coulam CB, Clark DA: Antiphospholipid antibody status and IVF-debate. Fertil Steril 2000;74:848-849
23. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P: High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278-2283
24. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Ching P, Ching W: The selective use of heparin/aspirin therapy alone of in combination with intravenous immunoglobulin G, in the management of anti-phospholipid antibody-positive women undergoing IVF. Am J Reprod Immunol 1998;40:74-82
25. Kutteh WH, Yetman DL, Chantilis SJ, Crain J: Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: Role of heparin and aspirin. Hum Reprod 1997;12:1171-1175
26. Coulam CB, Roussev RG: Correlation of NK cell activation and inhibition markers with NK cytotoxicity among women experiencing immunological implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003;20:58-62
27. Coulam CB, Roussev RG: Increasing circulating T-cell activation markers are linked to subsequent implantation failure after transfer of in vitro fertilized embryos. Am J Reprod Immunol 2003;50:340-345
28. Aoki K, Kajijura S, Matsumoto Y, Okada S, Yagami Y, Gleicher N: Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 1995;135:1340-1342
29. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Preconceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with a normal karyotype. Am J Reprod Immunol 2003;50:351-354
30. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gillman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003;18:767-773
31. Moffet A, Regan L, Braude P: Natural killer cells, miscarriage, and infertility. Br Med J 2004;329:1283-1285
32. Clark DA, Yu G, Levy GA, Gorczynski RM: Procoagulants in fetus rejection: The role of the OX-2 (CD200) tolerance signal. Semin Immunol 2001;13:255-263
33. Lachapelle MH, Miron P, Hemmings R, Roy DA: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol 1996;158:4886-4891
34. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996;35:352-359
35. Clark DA, Daya S, Coulam CB, Gunby J, and The Recurrent Miscarriage Immunotherapy Trialists Group: Implications of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996;35:495-498
36. Laudenslager ML, Aasal R, Adler L, Berger CL, Montgomery PT, Sandberg E, Wahlberg LJ, Wilkins RT, Zweig L, Reit ML: Elevated cytotoxicity in combat-veterans with long-term post-traumatic stress disorder: Preliminary observations. Brain Behav Immun 1998;12:74-79
37. Clark DA, Croitoru K: TH1/TH2,3 imbalance due to cytokine-producing NK, γδT and NKγδyT cells in murine deciduas in success or failure of pregnancy. Am J Reprod Immunol 2001;45:108-115
38. Mincheva-Nilsson L, Kling M, Hammarstrom S, Nagaeva O, Sundqvist KG, Hammarstrom ML, Baranov V: γδ T cells of human early pregnancy decidua: Evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 1997;159:3266-3277
39. Nagaeva O, Bondestam K, Olofsson J, Damber MG, Mincheva-Nilsson L: An optimized technique for separation of human decidual leukocytes for cellular and molecular analyses. Am J Reprod Immunol 2002;47:203-212
40. Nagaeva O, Jonsson L, Mincheva-Nilsson L: Dominant IL-10 and TGF-β mRNA expression in γδT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 2002;48:9-17
41. Szekeres-Bartho J, Barakonyi A, Miko E, Polgar B, Palkovics T: The role of γ/δ T cells in the feto-maternal relationship. Semin Immunol 2001;13:229-233
42. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995;273:1933-1936
43. Hamai Y, Fujii T, Yamashita T, Miki A, Kozuma S, Geraghty DE, Taketani Y: Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells. Am J Reprod Immunol 1998;40:408-413
44. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Intravenous immunoglobulins inhibits natural killer activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996;35:370-375
45. Kwak JY, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996;35:363-369
46. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Effects of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion. J Reprod Immunol 1996;31:125-141
47. Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M: Effect of intravenous immunoglobulins treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions. Am J Reprod Immunol 2003;49:21-29
48. Perricone R, De Carolis C, Giacomelli R, Guarino MD, De Sanctis G, Fontana L: GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reversed by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003;50:232-237
49. Sjoblom C, Wikland M, Robertson SA: Granulocytemacrophage colony stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod 2002;67:1817-1823
50. Regan L, Backos MJ, Rai R: Immunological testing and interventions for reproductive failure. RCOG (UK) Scientific Advisory Committee Opinion Paper #5, 2003. Retreived from http://www.rcog.org.uk/resources/Public/ SAC_Opinion_Paper _5.pdf
51. Coulam CB, Krysa L, Stern JJ, Bustillo M: Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995;34:333-337
52. Kiprov DD, Nachtigall RD, Weaver RC, Jacaobson A, Main EK, Garvoy MR: The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996;36:228-234
53. Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE: Successful treatment of immunological abortion with low-dose intravenous immunoglobulin. Fertil Steril 2000;73:536-540
54. Stephenson MD, Dreher K, Houlihan E, Wu V: Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blind, placebo-controlled trial. Am J Reprod Immunol 1998;39:82-88
55. Anonymous: Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group. Br J Obstet Gynaecol 1994;101:1072-1077
56. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N: Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995;10:2690-2695
57. Christiansen OB, Pedersen B, Rosgaard A, Husth M: A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: Evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002;17:809-816
58. Perino A, Vassiliadis A, Vucetich A, Colacurci N, Menato G, Cignitti M, Semprini AE: Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blind placebo-controlled Italian study. Hum Reprod 1997;12:2388-2392
59. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjelberg S, Lindton B: Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebo-controlled study. Hum Reprod 1999;14:838-841
60. Ratko TA, Burnett DA, Foulke GE, Matszewski KA, Sacher RA, and the University Hospital Consortium Expert Panel for Off-Label use of Polyvalent Intravenously Administered Immunoglobulin Preparations: Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995;273:1865-1870
61. Clark DA: Is there any evidence for immunologically-mediated or immunologically-modifiable early pregnancy failure? J Assist Reprod Genet 2003;20:62-71
62. Munne S, Sultan KM, Weler HU, Grifo JA, Cohen J, Rosenwaks Z: Assessment of numeric abnormalities of X, Y, 18 and 16 chromosomes in preimplantation human embryos before transfer. Am J Obstet Gynecol 1995;172:1191-1199
63. Clark DA, Ding J, Yu G, Levy GA, Gorczynski RM: Fgl2 prothrombinase expression in mouse trophoblast and deciduas triggers abortion but may be countered by OX-2. Mol Hum Reprod 2001;7:185-194
64. Knackstedt M, Ding JW, Arck PC, Hertwig K, Coulam CB, August C, Lea R, Dudenhausen JW, Gorczynski RM, Levy GA, Clark DA: Activation of the novel prothrombinase fgl2 as a basis for the pregnancy complications spontaneous abortion and preeclampsia. Am J Reprod Immunol 2001;46:196-210
65. Clark DA, Foerster K, Fung L, He W, Lee L, Mendicino M, Markert U, Gorczynski RM, Marsden P, Levy GA: The fgl2 prothrombinase/fibroleukin gene is required for LPS-triggered abortions and for normal hemostasis during murine reproduction. Mol Hum Reprod 2004;10:99-108
66. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH: Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64-68
67. Clark DA, Manuel J, Lee L, Chaouat G, Gorczynski RM, Levy GA: Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/2 model. I. Synergistic effect of LPS and (TNF-α + IFN-γ) on pregnancy loss. Am J Reprod Immunol 2004;52:370-378
68. Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM: MD-1 is a critical part of the mechanism causing Th-1 cytokine-triggered fetal loss syndrome. Am J Reprod Immunol 2003;49:297-307
69. Chaouat G, Ledee-Bataille N, Zourbas S, Ostojic S, Dubanchet S, Martal J, Frydman R: Cytokines, implantation and early abortion: Re-examining the Th1/Th2 paradigm leads to question the single pathway, single therapy concept. Am J Reprod Immunol 2003;50:177-186
70. De Carolis C, Greco E, Guarino MD, Perricone C, Dal Lango A, Giacomelli R, Fontana L, Perricone R: Anti-thyroid antibodies and anti-phospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol 2004;52:263-266
71. Clark DA, Banwatt D, Chaouat G: Stress-triggered abortion in mice is prevented by alloimmunization. Am J Reprod Immunol 1993;29:141-147
72. Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC: Reduced indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am J Reprod Immunol 2005;54:203-216
73. Simon HU, Sapth PJ: IVIG-mechanisms of action. Allergy 2003;58:543-552
74. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Lin M-R, Brown MH, Sedgwick JD, Phillips JH, Barclay AN: Characterization of the CD200 receptor family in mice and humans and their interaction with CD200. J Immunol 2003;171:3034-3046
75. + Treg using monoclonal antibodies to CD200R. Transplantation 2005;79:488-491
76. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004;5:266-271
77. + T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005;166:811-822